Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Angina IV: Management

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials.

Trials·2021

Same author

Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City.

AJNR. American journal of neuroradiology·2020

Same author

Association between liver fibrosis and cognition in a nationally representative sample of older adults.

European journal of neurology·2020

Same author

Higher early recurrence risk and potential benefit of dual antiplatelet therapy for minor stroke with watershed infarction: subgroup analysis of CHANCE.

European journal of neurology·2020

Same author

Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2020

Same author

The Future of Neurocritical Care Research: Proceedings and Recommendations from the Fifth Neurocritical Care Research Network Conference.

Neurocritical care·2019

Search research articles

Related Experiment Videos

Inpatient statin use predicts improved ischemic stroke discharge disposition.

A C Flint¹, H Kamel, B B Navi

¹Department of Neuroscience, Kaiser Permanente, Redwood City, CA, USA. alexander.c.flint@kp.org

|May 23, 2012

Summary

This summary is machine-generated.

Statin use before and during ischemic stroke hospitalization is linked to better discharge outcomes. Discontinuation of statins was associated with poorer discharge results, indicating their importance in stroke recovery.

Related Experiment Videos

Area of Science:

Cardiovascular Medicine
Neurology
Pharmacology

Background:

Ischemic stroke is a leading cause of long-term disability.
Discharge disposition significantly impacts patient recovery and healthcare resource utilization.
Statins are widely used for cardiovascular risk reduction, but their specific role in stroke recovery is an area of ongoing research.

Purpose of the Study:

To investigate the association between statin use and discharge disposition following ischemic stroke.
To evaluate if pre-stroke and in-hospital statin use influences where patients are discharged.
To assess the impact of statin withdrawal on stroke patient discharge outcomes.

Main Methods:

A retrospective analysis of 12,689 ischemic stroke patients over seven years.
Generalized ordinal logistic regression was employed to analyze discharge disposition.
Instrumental variable methods, including grouped-treatment and last prior treatment analyses, were used to address potential confounding factors.

Main Results:

Statin users demonstrated a significantly higher likelihood of discharge to home or a healthcare institution.
Patients experiencing statin withdrawal showed a reduced probability of favorable discharge outcomes.
Instrumental variable analyses confirmed that higher inpatient statin use probability correlated with better discharge to home outcomes.

Conclusions:

Statin use is strongly associated with improved discharge disposition after ischemic stroke.
Maintaining statin therapy during and after stroke may be crucial for optimizing patient recovery and functional outcomes.
These findings support the continued use of statins in patients with ischemic stroke.